Navigation Links
Clinical Results for Oramed's Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE
Date:5/1/2013

ection. Established in 2006, Oramed's technology is based on over 30 years of research by top research scientists at Jerusalem's Hadassah Medical Center. Oramed is seeking to revolutionize the treatment of diabetes through its proprietary flagship product, an orally ingestible insulin capsule (ORMD-0801) currently approaching Phase 2 clinical trials under an Investigational New Drug application with the U.S. Food and Drug Administration, and with its oral exenatide capsule (ORMD-0901; a GLP-1 analog), currently approaching Phase 2a trials. The company's corporate and R&D headquarters are based in Jerusalem.

For more information, the content of which is not part of this press release, please visit  http://www.oramed.com.

The company's fact sheet, the content of which is not part of this press release, can be viewed here.

Forward-looking statements: This press release contains forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995 and federal securities laws. For example, we are using forward-looking statements when we discuss the potential of ORMD-0810 as a treatment that can considerably aid a patient population resistant to standard anti-diabetes treatment protocols or our oral insulin and oral exenatide candidates approaching Phase 2 clinical trials and 2a clinical trials, respectively. These forward-looking statements are based on the current expectations of the management of Oramed only, and are subject to a number of factors and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements, including the risks and uncertainties related to the progress, timing, cost, and results of clinical trial
'/>"/>

SOURCE Oramed Pharmaceuticals Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Acutus Medical, Inc. Initiates "First-In-Man" Clinical Study of Real-Time 3D Imaging Catheter with CT/MRI Quality
2. Rush University Medical Center Presents Positive MuGard Clinical Data at the Oncology Nursing Society 38th Annual Congress
3. Oramed Pharmaceuticals to Present Results of its Key Clinical Studies of Oral Insulin in Type 1 Diabetes Patients at the GTC Diabetes Summit, Boston, MA; April 29-30, 2013
4. Cannabis Science announces preclinical development program for CS-TATI-I, commencing EU operations in the Netherlands and sourcing proprietary material for pharmacokinetic characterization
5. Elekta to Highlight Clinical and Safety Advantages of Gamma Knife Radiosurgery at 2013 AANS Meeting
6. Anterios, Inc., Announces Corporate Financing To Further Clinical Development Of Its Topical Botulinum Product
7. Top-line Data Show AcelRx Pharmaceuticals ARX-04 Achieves Primary Endpoint in Dose-Finding Phase 2 Clinical Trial
8. ISIS Pharmaceuticals Initiates a Clinical Study of ISIS-SMN Rx in Infants With Spinal Muscular Atrophy
9. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
10. Omeros to Present Additional OMS302 Clinical Data at the Annual ASCRS and ASOA Symposium and Congress
11. Savara Pharmaceuticals Initiates Phase 2 Clinical Trial of AeroVanc for MRSA Lung Infection in Cystic Fibrosis Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... , March 3, 2015 Dr. Cummins is ... greatest leaders in aesthetics. In addition to performing ... and Hand Surgery practice, Dr. Cummins now offers advanced ... Removal clinic . Dr. Cummins performs all treatments himself ... founded Louisville Tattoo Removal in order to help people ...
(Date:3/3/2015)... Calif. , March 3, 2015  BioPharmX Corporation ... development of novel drug delivery products to address unmet ... that Jim Pekarsky , chief executive officer and ... Annual Roth Capital Partners Conference on Wednesday, March ... Laguna Niguel in Dana ...
(Date:3/3/2015)... 2015  American Biosurgical, LLC ("ABI") ( www.americanbiosurgical.com ... actively engaged in the design, development and production ... leading medical device companies has announced the acquisition ... custom medical cable manufacturer based in North Carolina.  ... under the name MTI Medical Cables.  ...
Breaking Medicine Technology:Surgeon Owned And Operated Louisville Tattoo Removal Offers Astanza Duality Laser Treatments 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 2BioPharmX Corporation To Present At 27th Annual Roth Capital Partners Conference On March 11, 2015 3American Biosurgical Acquires MTI Corporation 2
... April 4, 2011 VIVUS, Inc. (Nasdaq: VVUS ... the investigational drug QNEXA® for two years showed reductions in ... as improvements in lipid levels following significant reductions in weight ... two years. The data – additional results ...
... ANGELES, April 4, 2011 NeuroSigma, Inc. ("NeuroSigma"), a ... develop early stage technologies with the potential to transform ... Investor Relations to design and execute its strategic communications ... to working closely with CCG to establish and enhance ...
Cached Medicine Technology:Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 2Weight Loss With QNEXA® Over Two Years Provides Patients With Substantial Cardiovascular Benefits 3NeuroSigma, Inc. Retains CCG Investor Relations 2NeuroSigma, Inc. Retains CCG Investor Relations 3
(Date:3/3/2015)... The Rheumatology Nurses Society (RNS) is ... and safe practice for patients with rheumatic diseases. , ... infusions are administered in an infusion center, provider’s office, ... nurse (RN), as defined in their State Nurse Practice ... receiving these medications during a first infusion, as well ...
(Date:3/3/2015)... Dr. Michael Nochomovitz has ... clinical integration and network development officer for ... established role, Dr. Nochomovitz is responsible for ... physician enterprise, its integration within NewYork-Presbyterian and ... Physicians. , Dr. Nochomovitz brings 17 years ...
(Date:3/3/2015)... NY (PRWEB) March 03, 2015 Topical BioMedics, ... as a webinar streamed live on Tuesday, March 10th, 12pm ... will be archived and accessible 24/7. , ... public. The topic for the March 10th workshop is “Opioid ... discussion, considering that the U.S. represents 5% of the world’s ...
(Date:3/3/2015)... March 03, 2015 The number of ... 1984 to about 15%. This increases to 50% by ... T, Cook JL, Yuzpe AA, et al. Estimating the ... 738-46). Dr. Jason Hitkari, a reproductive endocrinologist and co-director ... of TCM and clinical director and founder of Acubalance ...
(Date:3/3/2015)... Introducing 3D Digital Technologies to their state-of-the-art facilities, ... Digital Dentistry. Acute precision in 3D Digital ... no room for error during the manufacturing process. ... to significantly reduce “chair time” and cut material ... reducing labor and material costs proving to be ...
Breaking Medicine News(10 mins):Health News:Administration of Biologic Infusions: A Position Statement of the Rheumatology Nurses Society 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 2Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 3Health News:Dr. Michael Nochomovitz to Lead Clinical Integration and Network Development for the NewYork-Presbyterian Healthcare System 4Health News:Topical BioMedics Hosts March Pain Management Webinar 2Health News:Topical BioMedics Hosts March Pain Management Webinar 3Health News:Topical BioMedics Hosts March Pain Management Webinar 4Health News:Topical BioMedics Hosts March Pain Management Webinar 5Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 2Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 3Health News:New Treatment Approach Helps Boost Chance of Pregnancy; Information Seminar at Olive Fertility Center 4Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 2Health News:Iverson Dental Labs Introduces 3D Digital Dental Technology for Superior Products 3
... Agency advises against everything but jars of peanut butter ... Keebler peanut butter cookies; toll at 453 sickened, 6 ... 17 (HealthDay News) -- The U.S. Food and Drug ... butter products containing peanut butter or peanut butter paste, ...
... peanut butter cookies; FDA asks more companies to test ... sick in 43 states and 1 in Canada, and ... -- Cereal giant Kellogg recalled 16 products containing peanut ... investigation into peanut products possibly contaminated with salmonella. , ...
... chance to win up to $2,500 and promote colon-cancer ... Hutchinson Cancer Research Center,s "Get Screened" video contest - ... the importance of colorectal-cancer screening - has been extended ... Center,s ongoing awareness campaign - "Your colon. Your ...
... Jan. 16 Crdentia Corporation (the "Company") today has ... the Company,s non-reporting status. In conjunction with this, ... conjunction with its transfer agent, Computershare. All share ... listed below for reissuance of new share certificates, although ...
... ARLINGTON, Va., Jan. 16 Despite growing numbers on the ... involved in fatal collisions during 1997-2006 than in years past, ... deaths among drivers 70 and older fell 21 percent during ... of people 70 and older rose 10 percent. Compared with ...
... KJT Group announces a former Harris Interactive executive has joined ... pleased to announce the appointment of J. Scott Moller, M.S. ... Rochester, Mr. Moller has a BA in Economics and Political ... Analysis from the University of Rochester . Before ...
Cached Medicine News:Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 2Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 3Health News:FDA Warns Consumers Not to Eat Peanut Butter Products 4Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 2Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 3Health News:Kellogg Recalls 16 Products as Salmonella Probe Widens 4Health News:'Get Screened' Video Contest Deadline Extended to Jan. 30 2Health News:Crdentia Corp. Finalizes Reverse Stock Split 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 2Health News:Contrary to Earlier Predictions, Older Driver Fatal Crashes Trend Down 3Health News:KJT Group L.L.C. Continues Solid Growth 2
0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
... Catheter is indicated for balloon ... of a coronary artery or ... purpose of improving myocardial perfusion. ... also designed to provide distal ...
16mm from Mid-screw to Tips, blunt tips; overall length 110mm; Stainless Steel...
16mm from Mid-Screw to Blunt Tips, Gently Curved Blades; overall length 120mm; Stainless Steel...
Medicine Products: